Index Surge: Sensex, Nifty Rally Amid Sectoral Strength as Big Caps Recover

Index Surge: Sensex, Nifty Rally Amid Sectoral Strength as Big Caps Recover

Index Surge: Sensex, Nifty Rally Amid Sectoral Strength as Big Caps Recover​

The Indian stock markets witnessed a strong rebound on July 9, successfully bouncing back from significant correction seen in the previous session. Driven by broad-based buying across various sectors, benchmark indices closed comfortably in positive territory, signaling a firm recovery after intraday volatility.

At market close, the Sensex gained 238.22 points or 0.31 percent, settling at 76,741.82. The Nifty 50 climbed 80.75 points or 0.34 percent, finishing the session at 23,962.80. The index had previously touched an intraday high of 24,134.70 before profit booking trimmed some gains in the latter half.

Broader Indices Lead Gains as Corporate Stocks Hit 52-Week Highs​

Broader indices demonstrated resilience during the session. The Nifty Midcap 100 index rose notably by 1.4 percent, while the Nifty Smallcap 100 index gained 1.8 percent. This robust performance highlights strength beyond the top 50 companies.

Furthermore, the market saw significant positive individual stock movement. Over 100 stocks on the BSE reached their 52-week high during the day. Companies like Capri Global, Welspun Corp, Aether Industries, and Titan Company were among those reaching milestone highs.

Sectoral Performance: Realty Tops Gains as IT and Auto See Mild Dips​

Sectoral performance was largely positive across the market spectrum. Nifty Realty emerged as a standout performer, surging 3.5 percent. Other strong sectors included Nifty Media (2 percent), Nifty PSU Bank (1.6 percent), and Nifty Consumer Durables (1.6 percent).

The technology and automotive sectors, however, faced headwinds. Nifty IT slipped by 0.47 percent, while Nifty Auto declined 0.25 percent. This sectoral drag contrasted with the rally in realty and consumer-focused segments.

Individual Stock Movers: Sun Pharma Leads While Drug Bets Face Scrutiny​

In terms of stock performance, pharmaceutical and banking stocks were among the primary drivers. Sun Pharma led the gains for constituents, rising 2.6 percent. Bharti Airtel also performed strongly, climbing 2.2 percent, while InterGlobe Aviation registered a gain of 2 percent. Kotak Mahindra Bank posted a rise of 1.9 percent.

On the downside, pharmaceutical stocks faced challenges. Dr Reddy's Laboratories was reported as the biggest loser, falling 5.9 percent after certain batches of Semaglutide were found to be out of specification. Infosys declined 1.7 percent and Maruti Suzuki dipped by 1.6 percent.

Analyst Outlook: Technical Viewpoints Focus on Support Zones​

Analysts suggest a volatile yet hopeful near-term outlook. Sudeep Shah, Head - Technical and Derivatives Research at SBI Securities, stated that the 23800 to 23780 zone is likely to act as an immediate support area for Nifty, given that multiple previous swing lows reside in this region.

Regarding future upside, Shah noted that the 24070 to 24100 zone stands as a likely hurdle area for the index in the short term. Nagaraj Shetti, Senior Technical Research Analyst at HDFC Securities, observed that while the underlying trend remains choppy, there is an indication of a bounce back from near the support of 23800 levels.

Foreign Exchange and Market Movers​

The Indian rupee strengthened against the US dollar on July 9, rebounding by 17 paise to settle at 95.38. This move compared favorably against the previous session's rate of 95.55 per dollar.

Beyond the broad indices, several individual company milestones were noted. SML Mahindra gained 5 percent after reporting healthy growth in June production and commercial vehicle sales. NLC India climbed 3 percent subsequent to signing a joint venture agreement with NALCO for a power plant development.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top